"10.1371_journal.pone.0080118","plos one","2013-11-08T00:00:00Z","Sharon Morein-Zamir; Martina Papmeyer; Alice Durieux; Naomi A Fineberg; Barbara J Sahakian; Trevor W Robbins","Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrookeâ€™s Hospital, Cambridge, United Kingdom; Behavioural and Clinical Neuroscience Institute (BCNI), University of Cambridge, Cambridge, United Kingdom; Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom; Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom; Department of Psychology, University of Cambridge, Cambridge, United Kingdom","Conceived and designed the experiments: SMZ BJS TWR. Performed the experiments: SMZ NAF MP. Analyzed the data: SMZ AD. Contributed reagents/materials/analysis tools: SMZ NAF. Wrote the manuscript: SMZ AD BJS TWR.","SMZ, MP and AD have have declared that no competing interests exist. NAF has consulted for Bristol-Myers Squibb, Glaxo-SmithKline, Lundbeck, and Servier; she has received research support from AstraZeneca, Cephalon, the European College of Neuropsychopharmacology, GlaxoSmithKline, Lundbeck, Servier, and Wellcome Trust. BJS has consulted for Boehringer-Ingelheim, Cambridge Cognition, Eli Lilly, GlaxoSmithKline, Novartis, and Shire; and she receives an honorarium from the Journal of Psychological Medicine. She holds a grant funded by Johnson and Johnson. TWR consults for Cambridge Cognition, Lilly, Lundbeck, Merck, Sharpe and Dohme, Shire Pharmaceuticals, Teva and Chempartners and also holds research grants from Lilly, Lundbeck and GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Sharon Morein-Zamir","SMZ",6,FALSE,3,3,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
